| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5578182 | Journal of Pain and Symptom Management | 2017 | 35 Pages |
Abstract
Various prognostic tools have been validated but vary in their complexity, subjectivity, and therefore clinical utility. The Glasgow Prognostic Score would seem the most favorable as it uses only two parameters (both objective) and has prognostic value complementary to the gold standard measure, which is performance status. Further studies comparing all proved prognostic markers in a single cohort of patients with advanced cancer are needed to determine the optimal prognostic tool.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Claribel P.L. MBChB, MRCP, Donald C. PhD, Kerry MBChB, MRCP, Tonje A. MD, PhD, Kenneth C. MD, Sharon BSc, Marie T. MD, Barry J. MD,